Daiichi Sankyo links with MorphoSys for anti-infective antibodies
This article was originally published in Scrip
Executive Summary
Daiichi Sankyo has extended its antibody discovery alliance with MorphoSys to include the development of novel therapeutic antibodies against nosocomial (hospital-acquired) infections.